
Julia Foldi, MD PhD
@juliafoldimd
Breast Medical Oncologist @UPMCHillmanCC @MageeWomens via @YaleHemeOnc @YaleIMed, @NYUGrossman, Immunology @WeillCornellGS.
ID: 1265714236883234821
27-05-2020 18:39:33
147 Tweet
464 Takipçi
343 Takip Edilen

Congrats, Fred Howard, such an important and huge analysis!


Are you living with oligometastatic #breastcancer? You may be eligible to participate in the Susan G. Komen supported CHLOE study which asks the question "can we cure oligometastatic HER2+ breast cancer?" Check out chloe.yalepathaws.org or contact Mariya Rozenblit #BCSM


Thank you, UPMC Hillman Cancer Center for the support, and to NRG Oncology for giving me this opportunity! Looking forward to meeting the other fellowship recipients this summer!

A little late in sharing the good news that on my second try, I got the @NIH_LRP funded by the National Cancer Institute this year! Only possible because of my amazing mentors from fellowship Yale Hematology Oncology Fellows and those UPMC Hillman Cancer Center Magee-Womens Research Institute & Foundation and their true collaborative nature! #NIHLRP


The upcoming #ILCSymposium is deadline for us to get papers on #lobular #breastcancer on #bioRxiv (and hopefully soon published) Adrian Lee #1: Osama Shiraz Shah, PhD used spatially-resolved transcriptomic, genomic, and single-cell approaches to study mixed ductal lobular brca 1/4🧵



Grateful and proud to speak about a topic near and dear to my heart alongside Ayaka Sugiura (Vanderbilt MSTP), Talia H. Swartz, and other inspiring women a in Nature Medicine Comment piece today! APSA #physicianscientists #doubledocs nature.com/articles/s4159…


1/ Breast cancer with chest wall metastases is a devastating disease with high unmet need. Translational Breast Cancer Research Consortium #TBCRC044 clinical trial led by Dr. Neelima Vidula MGH Breast Oncology and Hope Rugo is currently enrolling patients.





CDK4/6 inhibitors are transforming HR+/HER2- #BreastCancerTreatment. This review by Tara Magge, Sneha Rajendran, Adam Brufsky, & Julia Foldi, MD PhD highlights the benefits & limitations of these therapies & the emerging role of ribociclib & abemaciclib. 🗞️ link.springer.com/article/10.100…


Had a fantastic meeting at the #ILCsymposium in beautiful Leuven, Belgium organized by Christine Desmedt and her team! Lots to think about, and lot more progress that needs to be made! Dr. Steffi Oesterreich Adrian Lee



A Huge Round of thanks to all of our colleagues who joined us in the #OncoAlert5k Homecoming Run Here in our Home Town of San Antonio Texas 🇺🇸 #SABCS24 Matteo Lambertini, MD PhD 🇮🇹 Erika Hamilton, MD, FASCO 🇺🇸 Hope Rugo 🇺🇸 Janice Cowden 🇺🇸 Stephanie Graff, MD, FACP, FASCO 🇺🇸 Maryam Lustberg MD, MPH, FASCO 🇺🇸 Double Whammy 🇺🇸


So proud of my mentor and friend, Dr. Steffi Oesterreich, congratulations!! #ILC #SABCS24


Join us for an exciting discussion focusing on sequencing therapies in breast cancer with Josh Drago Julia Foldi, MD PhD Susan dent registration.onclive.com/state-of-the-s…
